Workflow
兴欣新材(001358) - 2025 Q3 - 季度财报
2025-10-28 08:05
Financial Performance - Q3 2025 revenue reached ¥137,554,328.71, an increase of 21.23% year-over-year[5] - Net profit attributable to shareholders decreased by 42.62% to ¥11,037,386.90 for Q3 2025[5] - Basic earnings per share fell by 43.75% to ¥0.09 for Q3 2025[5] - Total operating revenue for the current period reached ¥355,930,715.80, an increase of 7.4% compared to ¥331,809,994.02 in the previous period[22] - Net profit for the current period was ¥41,961,482.61, a decrease of 31.7% from ¥61,530,354.86 in the previous period[23] - Earnings per share (EPS) for the current period was ¥0.37, down from ¥0.51 in the previous period[24] Assets and Liabilities - Total assets increased by 1.45% to ¥1,578,029,840.26 compared to the end of the previous year[5] - Total assets amounted to ¥1,578,029,840.26, slightly up from ¥1,555,432,481.01 in the previous period[20] - Total liabilities increased to ¥146,718,049.31, compared to ¥98,181,521.95 in the previous period, reflecting a significant rise of 49.2%[20] - The company's cash and cash equivalents decreased from CNY 811,238,723.21 at the beginning of the period to CNY 379,478,470.09 at the end of the period, representing a decline of approximately 53.3%[17] Cash Flow - Cash flow from operating activities decreased by 55.67% to ¥30,771,962.65 year-to-date[5] - Operating cash inflow for the current period is CNY 282,864,378.84, a decrease of 11.3% from CNY 318,755,371.37 in the previous period[26] - Net cash outflow from operating activities is CNY 30,771,962.65, down 55.7% compared to CNY 69,419,396.27 in the previous period[27] - Cash inflow from investment activities is CNY 1,959,773,549.97, significantly higher than CNY 965,039,261.14 in the previous period, marking an increase of 103.5%[27] - Net cash outflow from investment activities is CNY -427,807,700.29, worsening from CNY -262,980,556.15 in the previous period[27] - Cash inflow from financing activities totals CNY 42,492,105.98, compared to CNY 4,643,193.96 in the previous period[27] - Net cash outflow from financing activities is CNY -33,506,518.64, an improvement from CNY -182,081,357.77 in the previous period[27] - The ending balance of cash and cash equivalents is CNY 379,478,470.09, down from CNY 679,542,121.24 in the previous period[27] Expenses - Sales expenses increased by 113.10% year-over-year, primarily due to market expansion efforts by a subsidiary[10] - Financial expenses decreased by 86.56% year-over-year, attributed to increased investments in financial assets[10] - Investment income rose by 118.52% year-over-year, linked to increased purchases of financial assets[10] - The company reported a significant increase in research and development expenses, which rose to ¥17,532,900.70 from ¥13,837,132.42, marking a growth of 26.3%[23] Project Developments - The company has established a wholly-owned subsidiary or holding subsidiary in the China-Malaysia Qinzhou Industrial Park for the investment and construction of a project with an annual output of 153,000 tons of polyamine series products[13] - As of the end of the reporting period, the company has completed the business registration of the project company and obtained the business license issued by the administrative approval bureau of the China-Malaysia Qinzhou Industrial Park[13] - The company has signed an investment contract with the China-Malaysia Qinzhou Industrial Park Management Committee, which does not constitute a related party transaction or a major asset restructuring[13] - The company has approved the establishment of Guangxi Xingxin New Materials Co., Ltd. in collaboration with other companies to implement the external investment project[13] Governance and Structure - The company has revised its articles of association and governance structure, eliminating the supervisory board and transferring its powers to the audit committee of the board of directors[15] - The company has confirmed the members of its audit committee, which continues to consist of three independent directors[15] Other Financial Information - The company reported a significant increase in prepayments from CNY 17,154,613.18 at the beginning of the period to CNY 11,343,749.66 at the end of the period, indicating a decrease of approximately 33.8%[17] - The company received CNY 1,952,000,000.00 from investment recoveries, a substantial increase from CNY 960,000,000.00 in the previous period[27] - Cash received from interest, fees, and commissions is not reported in the current period[26] - The company's trading financial assets increased significantly from CNY 115,000,000.00 at the beginning of the period to CNY 495,000,000.00 at the end of the period, marking an increase of approximately 330.4%[17] - Accounts receivable rose from CNY 44,207,851.59 at the beginning of the period to CNY 51,439,699.37 at the end of the period, reflecting an increase of about 16.5%[17] - The company's third-quarter financial report is unaudited[28]
漱玉平民(301017) - 2025 Q3 - 季度财报
2025-10-28 08:05
Financial Performance - The company's revenue for Q3 2025 reached ¥2,564,308,490.01, representing a year-on-year increase of 13.48%[4] - Net profit attributable to shareholders was ¥72,896,120.41, a significant increase of 294.98% compared to the same period last year[4] - The basic earnings per share rose to ¥0.18, marking a 300.00% increase year-on-year[4] - In the first three quarters of 2025, the company achieved operating revenue of CNY 744.55 million, a year-on-year increase of 5.19%, and a net profit attributable to shareholders of CNY 109.15 million, a significant increase of 927.37%[19] - The net profit excluding non-recurring gains and losses reached CNY 9.40 million, up 160.23% year-on-year[19] - Net profit for the period was ¥100,856,450.25, a significant recovery from a net loss of ¥28,498,927.90 in the previous year[35] - Operating profit improved to ¥147,147,406.05 compared to a loss of ¥1,623,384.50 in the same period last year[33] - Basic and diluted earnings per share were both ¥0.27, recovering from a loss of ¥0.03 per share in the previous year[36] - The company reported a total profit of ¥135,578,418.79, recovering from a loss of ¥16,285,037.28 in the same period last year[35] Assets and Liabilities - The total assets of the company increased to ¥10,018,705,946.99, reflecting an 8.04% growth from the previous year[7] - The company's goodwill increased by 30.21% to ¥2,281,932,857.80, primarily due to acquisitions during the reporting period[12] - The company’s liabilities increased, with accounts payable rising by 51.48% to ¥1,751,998,626.26, indicating higher purchase obligations[12] - The total current liabilities rose to ¥6,189,778,365.92 from ¥5,362,410,305.97, marking an increase of approximately 15.4%[30] - The total non-current liabilities decreased to ¥1,598,619,358.35 from ¥1,785,712,083.01, reflecting a decline of about 10.5%[31] - The company's total equity increased to ¥2,230,308,222.72 from ¥2,125,070,292.99, indicating a growth of approximately 4.9%[31] Cash Flow and Investments - The company reported a net cash flow from operating activities of ¥624,163,644.07, which is a 160.56% increase year-to-date[4] - Cash flow from operating activities generated a net inflow of ¥624,163,644.07, up from ¥239,543,017.67 in the prior year[38] - Investment activities resulted in a net cash outflow of ¥728,805,481.89, worsening from a smaller outflow of ¥21,901,815.19 in the previous year[38] Operational Metrics - The overall gross margin declined by 1.35% due to changes in industry policies, regulatory environments, and consumer behavior[20] - The company optimized its store network, resulting in a year-on-year improvement in the expense-to-sales ratio by 1.45%[20] - As of September 30, 2025, the company operated a total of 8,617 stores across several provinces, with 4,972 being direct-operated stores[21] - The company has a steady expansion strategy, having opened 3 new stores and acquired 754 stores while closing 223 stores in the reporting period[21] - A total of 1,939 convertible bonds were converted into 12,832 shares of stock by the end of September 2025[22] - The company continues to focus on a direct chain marketing model and regional deep cultivation strategies to enhance profitability[21] Market and Product Development - The company is diversifying its product offerings to include health products, healthcare items, medical devices, and beauty products to meet consumer demand[21] - The company reported a revenue increase of 15% year-over-year, reaching 1.2 billion RMB in Q3 2025[41] - User data showed a growth of 20% in active customers, totaling 5 million users by the end of Q3 2025[41] - New product launches contributed to a 25% increase in sales in the health supplement category[41] - The company is investing 50 million RMB in R&D for new technology aimed at improving customer experience[41] - Market expansion efforts have led to the opening of 30 new stores in tier-2 cities, increasing the total store count to 200[41] - The company is exploring potential acquisitions to enhance its product offerings and market presence[41] - A new marketing strategy is projected to increase brand awareness by 15% in the next quarter[41] - The gross margin improved to 35%, up from 32% in the previous quarter[41] - The company plans to allocate 10% of its revenue towards sustainability initiatives in the upcoming fiscal year[41] Other Financial Metrics - The company confirmed a fair value change gain of ¥127,905,105.59, a dramatic increase of 196,527.69% compared to the previous period[12] - The company's cash and cash equivalents decreased to ¥1,306,337,761.38 from ¥1,404,760,376.62, representing a decline of approximately 7.0%[27] - Inventory levels increased to ¥2,099,057,605.58 from ¥1,891,086,015.63, showing a rise of about 11.0%[28] - The company incurred a tax expense of ¥34,721,968.54, compared to ¥12,213,890.62 in the previous year, indicating a rise in tax obligations[35] - Total operating costs increased to ¥7,426,697,847.88 from ¥7,068,782,768.84, representing a rise of approximately 5.06% year-over-year[33] - The company decided not to adjust the conversion price of the "Shuyu Convertible Bonds" despite triggering conditions for downward adjustment, maintaining the price at ¥12.71 per share[25] - The company will reassess the conversion price adjustment rights if the conditions are triggered again after December 9, 2025[25]
中原内配(002448) - 2025 Q3 - 季度财报
2025-10-28 08:05
Financial Performance - The company's operating revenue for Q3 2025 reached ¥923,884,431, representing a year-on-year increase of 20.22%[5] - Net profit attributable to shareholders was ¥92,311,341, a significant increase of 64.72% compared to the same period last year[5] - The net profit excluding non-recurring gains and losses was ¥89,140,806, up 95.82% year-on-year[5] - Basic earnings per share increased to ¥0.16, reflecting a growth of 60.00% compared to the previous year[5] - Total operating revenue for the current period reached ¥2,866,662,106.94, an increase of 16.3% compared to ¥2,463,844,879.86 in the previous period[17] - Net profit for the current period was ¥369,006,786.03, representing a 43.5% increase from ¥256,935,153.05 in the previous period[18] - Basic and diluted earnings per share increased to ¥0.55 from ¥0.40, reflecting a growth of 37.5%[19] - The company reported a total comprehensive income of ¥369,255,055.90, compared to ¥264,013,665.79 in the previous period, reflecting a growth of 39.9%[19] Assets and Liabilities - Total assets as of September 30, 2025, amounted to ¥6,138,766,448, an increase of 5.68% from the end of the previous year[5] - The company's total current assets amount to ¥2,798,310,694.31, an increase from ¥2,644,860,455.49 at the beginning of the period[14] - Total assets reached ¥6,138,766,448.12, compared to ¥5,808,598,814.93 at the beginning of the period, marking a growth of approximately 5.7%[15] - The total non-current assets are valued at ¥3,340,455,753.81, up from ¥3,163,738,359.44, representing an increase of about 5.6%[15] - Total liabilities increased to ¥1,939,214,715.77, compared to ¥1,898,697,607.81 in the previous period, marking a growth of 2.1%[16] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥124,360,814.82, down 24.53% compared to the previous year[5] - Cash flow from operating activities generated a net amount of ¥124,360,814.82, down 24.5% from ¥164,776,803.34 in the previous period[19] - The cash inflow from investment activities was ¥422,737,454.62, a decrease from ¥856,257,928.22 in the previous period[19] - Net cash flow from investment activities was -$138.94 million, compared to -$8.48 million in the previous period, indicating a significant decline in investment performance[20] - Cash inflow from financing activities totaled $363.96 million, down from $653.86 million, reflecting a decrease of approximately 44%[20] - Net cash flow from financing activities improved to $33.06 million, compared to a negative $54.79 million in the previous period, showing a positive turnaround[20] - The total cash and cash equivalents at the end of the period increased to $406.59 million, up from $382.99 million, representing a growth of about 6%[20] Shareholder Information - The total number of common shareholders at the end of the reporting period is 59,130[11] - The largest shareholder, Xue Delong, holds 16.19% of shares, totaling 95,240,659 shares[11] - The company has a total of 9,388,100 shares held by Shenzhen Guoyuan Xinda Capital Management Co., Ltd. through various accounts[12] Investments and Expenses - The company reported a significant increase in construction in progress, which rose by 1082.81% to ¥265,436,298.63, primarily due to investments in a project in Thailand[9] - Research and development expenses rose to ¥136,106,440.04, an increase of 15.7% compared to ¥118,579,392.04 last year[18] - Total operating costs amounted to ¥2,477,898,529.79, up 10.6% from ¥2,239,747,524.16 in the prior period[17] Financial Position Changes - The company’s total equity attributable to shareholders increased by 7.18% to ¥3,728,010,517.74 compared to the end of the previous year[5] - Total equity attributable to shareholders of the parent company reached ¥3,728,010,517.74, up from ¥3,478,333,894.85, indicating a growth of 7.2%[16] - The company’s goodwill stands at ¥491,806,967.96, slightly down from ¥496,617,444.28, indicating a decrease of about 1.6%[15] Other Information - The company’s third-quarter financial report was not audited, which may affect the reliability of the reported figures[21] - The company will implement new accounting standards starting in 2025, which may impact future financial reporting[21]
赛托生物(300583) - 2025 Q3 - 季度财报
2025-10-28 08:05
Financial Performance - The company's operating revenue for Q3 2025 was ¥241,425,650.02, representing a year-on-year increase of 21.70%[4] - The net profit attributable to shareholders was -¥16,543,142.49, a significant decline of 1,199.98% compared to the same period last year[4] - The basic earnings per share for Q3 2025 was -¥0.08, reflecting a decrease of 900.00% year-on-year[4] - The total profit for the year-to-date was -¥75,201,207.54, a decline of 462.69% compared to the same period last year[9] - Net profit for the period was a loss of ¥79,128,524.62, compared to a profit of ¥13,200,659.89 in the previous period, indicating a significant decline[19] - Operating profit turned negative at -¥74,138,162.11, down from a positive ¥21,181,969.70 in the prior year[19] - Basic and diluted earnings per share were both -¥0.36, compared to ¥0.08 in the previous period[20] Cash Flow - The cash flow from operating activities for the year-to-date was ¥77,809,222.82, down 53.96% from the previous year[4] - The net cash flow from operating activities was $77.81 million, a decrease of 54% compared to $169.01 million in the previous period[22] - Cash inflow from operating activities totaled ¥553,336,844.67, down from ¥607,886,012.30, a decrease of approximately 8.9% year-over-year[21] - Cash outflows from operating activities totaled $475.53 million, compared to $438.87 million in the prior period[22] - The net cash flow from investing activities was -$27.43 million, an improvement from -$61.30 million year-over-year[22] - Cash inflows from investment activities totaled $10.52 million, significantly higher than $2.36 million in the prior period[22] Assets and Liabilities - Total assets at the end of Q3 2025 were ¥2,866,079,082.42, a decrease of 5.28% from the end of the previous year[4] - Total current assets decreased from 1,284,916,162.65 CNY to 1,189,810,971.39 CNY, a decline of approximately 7.41%[14] - Total assets decreased from 3,025,806,782.53 CNY to 2,866,079,082.42 CNY, a decline of approximately 5.26%[14] - Total non-current assets decreased from 1,740,890,619.88 CNY to 1,676,268,111.03 CNY, a decline of approximately 3.71%[14] - The total liabilities decreased to ¥1,064,836,700.02 from ¥1,141,641,832.99, a reduction of approximately 6.7%[19] - Total equity attributable to shareholders decreased to ¥1,766,097,218.21 from ¥1,839,121,540.57, a decline of about 4.0%[19] Shareholder Information - Total number of common shareholders at the end of the reporting period is 13,737[11] - The largest shareholder, Shandong Runxin Investment Co., Ltd., holds 22.82% of shares, totaling 43,297,382 shares, with 7,440,000 shares pledged[11] - The second-largest shareholder, Mi Chaojie, holds 20.62% of shares, totaling 39,116,800 shares[11] Investment and Expenses - The company experienced a 50.40% decrease in investment income, totaling ¥5,391,355.27 for the year-to-date[8] - Research and development expenses were ¥32,249,551.03, down from ¥41,391,541.00, reflecting a reduction of about 22.1%[19] - Cash paid to employees was $83.66 million, down from $107.49 million year-over-year[22] - Cash paid for taxes was $23.87 million, a decrease from $40.83 million in the previous period[22] - Cash paid for the acquisition of fixed assets was $34.96 million, down from $63.66 million year-over-year[22] Credit and Impairment - The company reported a 514.07% increase in credit impairment losses, amounting to -¥9,637,137.21 for the year-to-date[8] - The company reported a credit impairment loss of -¥9,637,137.21, compared to a gain of ¥2,327,445.50 in the previous period[19]
民德电子(300656) - 2025 Q3 - 季度财报
2025-10-28 08:05
证券代码:300656 证券简称:民德电子 公告编号:2025-067 深圳市民德电子科技股份有限公司 2025 年第三季度报告 深圳市民德电子科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重 大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是否 1 深圳市民德电子科技股份有限公司 2025 年第三季度报告 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是否 | | 本报告期 | 本报告期比上年同 | 年初至报告期末 | | 年初至报告期末 | | --- | --- | --- | --- | --- | --- | | | | 期增减 | | | 比上年同期增减 | | 营业收入(元) | 94,129, ...
凯普生物(300639) - 2025 Q3 - 季度财报
2025-10-28 08:05
Financial Performance - The company's operating revenue for Q3 2025 was ¥170,878,580.77, a decrease of 15.14% compared to the same period last year[5] - The net profit attributable to shareholders was -¥38,091,900.98, representing an increase in loss of 79.41% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥39,779,349.67, an increase in loss of 78.44% year-on-year[5] - The company achieved total operating revenue of CNY 48,587.17 million, representing a year-on-year decline of 20.38%[17] - The net profit attributable to shareholders was -CNY 12,768.33 million, with a year-on-year loss reduction of 51.25%[17] - The company reported a net profit attributable to shareholders after deducting non-recurring gains and losses of -CNY 13,538.97 million, a 49.89% reduction in loss compared to the previous year[17] - Operating profit showed a loss of ¥170.83 million, an improvement from a loss of ¥456.83 million in the previous period[28] - Net profit loss narrowed to ¥189.38 million compared to a loss of ¥400.72 million in the same period last year, indicating a 52.8% improvement[28] - The company reported a total comprehensive loss of ¥226.52 million, compared to a loss of ¥407.28 million in the previous period, showing a 44.3% improvement[29] Cash Flow and Assets - The cash flow from operating activities for the year-to-date was ¥121,210,400.21, an increase of 173.06%[5] - The company reported a net cash flow from operating activities of CNY 12,121.04 million for the first nine months of 2025, a 173.06% increase compared to CNY 4,438.94 million in the same period of 2024, primarily due to reduced salary and tax payments[13] - The company experienced a net cash flow from investing activities of -CNY 2,515.14 million, a significant decrease of 114.98% from CNY 16,794.77 million in the previous year, mainly due to increased purchases of financial products[13] - The net increase in cash and cash equivalents was CNY 2,267.13 million, down 84.31% from CNY 14,453.46 million in the prior year, attributed to increased investments in financial products[13] - Cash flow from operating activities generated ¥121.21 million, a significant increase from ¥44.39 million in the previous period[31] - Cash and cash equivalents at the end of the period totaled ¥684.79 million, down from ¥905.90 million year-over-year[31] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,282,405,863.85, a decrease of 7.37% from the end of the previous year[5] - The total assets as of September 30, 2025, amounted to CNY 4,282,405,863.85, a decrease from CNY 4,622,985,300.71 at the beginning of the period[24] - The total liabilities as of September 30, 2025, were CNY 553,762,084.98, down from CNY 576,437,152.67 at the beginning of the period[25] - The company's current assets totaled CNY 1,976,063,479.06, a decrease from CNY 2,225,642,938.29 at the beginning of the period[24] - The company's non-current assets amounted to CNY 2,306,342,384.79, down from CNY 2,397,342,362.42 at the beginning of the period[24] - The company's cash and cash equivalents decreased to CNY 696,757,930.99 from CNY 712,357,379.26 at the beginning of the period[23] - The company's inventory increased to CNY 79,475,140.68 from CNY 65,662,916.94 at the beginning of the period[24] Operational Developments - The company has developed a new respiratory pathogen nucleic acid testing kit, which received a Class III medical device registration certificate from the National Medical Products Administration[18] - The company is focusing on enhancing the operational quality and efficiency of its "Kepu Kang and Medical Testing 5.0 Project" to improve revenue from high-value projects and reduce operational costs[17] - The company plans to strengthen the collection of accounts receivable and optimize its medical testing laboratory business to increase revenue from high-margin projects[17] - The company has obtained a total of 98 medical device registration certificates, including 35 Class III medical device registration certificates, and 59 CE certifications, with 26 under the new EU Medical Device Regulation IVDR[19] - The company has accumulated 219 patent authorizations, including 130 domestic and international invention patents, with 12 new invention patents authorized during the reporting period[19] Governance and Management - The company completed the adjustment of its governance structure and the election of the sixth board of directors, enhancing its operational standards[20] - The company has appointed a new board of directors and senior management during the first extraordinary shareholders' meeting held on September 10, 2025[21] Accounting and Reporting - The third quarter financial report of Guangdong Cape Biotechnology Co., Ltd. has not been audited[33] - The new accounting standards will be implemented starting from 2025, affecting the financial statements from the beginning of that year[32]
隆鑫通用(603766) - 2025 Q3 - 季度财报
2025-10-28 08:05
隆鑫通用动力股份有限公司 2025 年第三季度报告 重要内容提示: 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假记载、误 导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 (一) 主要会计数据和财务指标 证券代码:603766 证券简称:隆鑫通用 隆鑫通用动力股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 单位:元 币种:人民币 | | | 本报告期 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 比上年同 | 年初至报告期末 | 末比上年同期 | | | | 期增减变 | | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 4,804,994,497.01 | 5.55 | 14,556, ...
华丽家族(600503) - 2025 Q3 - 季度财报
2025-10-28 08:05
Financial Performance - The company's operating revenue for the third quarter was CNY 31,376,634.95, a decrease of 70.52% compared to the same period last year[5] - The total profit for the quarter was a loss of CNY 15,888,310.92, representing a decline of 540.64% year-on-year[5] - The net profit attributable to shareholders was a loss of CNY 15,645,044.96, with a year-to-date loss of CNY 26,057,463.00, reflecting a decrease of 1,639.78%[5] - Total revenue for the first three quarters of 2025 was CNY 169,351,178.50, a decrease of 35.5% compared to CNY 262,802,218.50 in the same period of 2024[21] - Operating profit for the first three quarters of 2025 was a loss of CNY 27,268,215.64, compared to a profit of CNY 13,502,763.70 in 2024[22] - Net profit for the first three quarters of 2025 was a loss of CNY 26,544,627.96, compared to a profit of CNY 2,028,787.97 in the same period of 2024[22] - Basic and diluted earnings per share for the first three quarters of 2025 were both CNY -0.0163, compared to CNY 0.0011 in 2024[23] Cash Flow and Assets - The cash flow from operating activities for the year-to-date was CNY 76,104,823.69[6] - The net cash flow from operating activities for the current period is 155.11 million RMB, primarily due to an increase in advance payments received from subsidiaries[11] - Operating cash inflow totaled $461.14 million, up from $286.29 million year-over-year[26] - Net cash flow from operating activities was $76.10 million, a significant improvement from a net outflow of $299.28 million in the previous period[26] - Total cash outflow from operating activities was $385.04 million, compared to $585.57 million in the prior year[26] - The ending cash and cash equivalents balance was $739.98 million, down from $769.94 million at the end of the previous period[27] Assets and Liabilities - The total assets at the end of the reporting period were CNY 4,664,804,552.05, an increase of 5.19% from the end of the previous year[6] - The total current assets as of September 30, 2025, amount to 3,481.70 million RMB, showing a slight increase from 3,465.36 million RMB at the end of 2024[18] - Total liabilities increased to CNY 1,042,711,329.50 from CNY 786,084,943.34, representing a growth of 32.6%[20] - Non-current liabilities totaled CNY 303,750,578.82, up from CNY 276,835,299.07, indicating an increase of 9.5%[20] - The company reported a significant increase in contract liabilities, rising to CNY 388,119,826.83 from CNY 178,543,196.34, a growth of 117.0%[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 112,998, with the largest shareholder holding 7.12% of the shares[14] - The equity attributable to shareholders decreased by 0.73% to CNY 3,554,540,009.19 compared to the end of the previous year[6] Investment and Expenses - Long-term equity investments decreased by 82.78 million RMB due to project exits during the year-to-date[11] - The company reported an increase in other income of 482.67 million RMB, attributed to penalties received as per contract agreements[11] - Research and development expenses were reported at -100.00 million RMB, indicating no R&D investment during the year-to-date[11] Future Outlook - The company plans to implement new accounting standards starting in 2025, which may affect financial reporting[28]
天成自控(603085) - 2025 Q3 - 季度财报
2025-10-28 08:05
浙江天成自控股份有限公司 2025 年第三季度报告 证券代码:603085 证券简称:天成自控 浙江天成自控股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存 在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 (一) 主要会计数据和财务指标 1 / 11 单位:元 币种:人民币 项目 本报告期 本报告期 比上年同 期增减变 动幅度(%) 年初至报告期末 年初至报告期 末比上年同期 增减变动幅度 (%) 营业收入 699,216,859.91 21.07 1,854,933,263.18 27.30 利润总额 39,616,801.93 219.47 76,015,736.14 263.83 归属于上市公司股东的 净 ...
罗曼股份(605289) - 2025 Q3 - 季度财报
2025-10-28 08:05
Financial Performance - The company's operating revenue for the third quarter reached ¥299,747,290.94, an increase of 50.74% compared to the same period last year[5] - The total profit for the period was ¥10,470,734.27, reflecting a decrease of 9.56% year-over-year[5] - The net profit attributable to shareholders was ¥7,858,104.88, down 26.30% from the previous year[5] - The net profit excluding non-recurring gains and losses was ¥6,132,148.25, an increase of 25.97% year-to-date[5] - The basic earnings per share for the quarter was ¥0.07, a decrease of 22.22% compared to the same period last year[6] - The net profit for the year-to-date period increased by 33.55% due to reduced impairment losses on receivables[9] - The net profit for the first three quarters of 2025 reached ¥20,873,763.06, a significant increase from ¥11,315,607.23 in the same period of 2024, representing an 84.5% growth[26] - The total profit for the first three quarters of 2025 was ¥31,259,285.23, up from ¥16,518,695.19 in 2024, indicating a 89.5% increase[26] Assets and Liabilities - The total assets of the company increased to ¥2,889,794,052.41, representing a growth of 29.14% from the end of the previous year[6] - The company's total assets increased to CNY 2,255,465,467.37 as of September 30, 2025, up from CNY 1,871,330,528.76 on December 31, 2024, representing a growth of approximately 20.5%[31][33] - Total liabilities increased to ¥1,533,420,478.29 as of September 30, 2025, compared to ¥961,178,424.14 at the end of 2024, representing a growth of 59.6%[23] - The company's total liabilities increased to CNY 927,978,816.48 as of September 30, 2025, up from CNY 579,596,236.36 at the end of 2024, indicating a rise of about 60.0%[32][33] Cash Flow - The company reported a cash flow from operating activities of -¥130,113,136.30 year-to-date[5] - The net cash flow from operating activities for the first three quarters of 2025 was -¥130,113,136.30, an improvement compared to -¥158,225,558.11 in 2024[28] - The company's cash flow from operating activities showed a net outflow of CNY -137,294,012.03 for the first three quarters of 2025, slightly worse than the outflow of CNY -132,182,550.20 in 2024[37] - The cash inflow from financing activities for the first three quarters of 2025 was ¥333,265,336.71, a substantial rise from ¥47,907,729.33 in 2024[29] - The company incurred a net cash outflow from investing activities of -¥3,089,373.19, an improvement from -¥182,498,474.82 in the previous year[29] Shareholder Information - The total number of common shareholders at the end of the reporting period was 10,239[12] - The largest shareholder, Sun Jianming, holds 19,657,500 shares, representing 18.03% of the total shares[12] - The top ten shareholders do not participate in margin trading or securities lending activities[13] Strategic Initiatives - The company successfully secured two significant energy storage projects with a total capacity of 50MW and 89.44MWh, marking a strong foothold in the energy storage sector[17][18] - The company’s immersive night tour project based on the "Harry Potter" IP is set to launch in Shenzhen in the second half of 2025, marking its first entry into the mainland China market[19] - The company’s services for the Shanghai International Light Festival attracted over 21.8 million participants, enhancing its market presence in the light art sector[15] - The company has established a comprehensive service matrix for the Shanghai International Light Festival, involving 1 main venue and 8 sub-venues[14] - The company is focusing on deepening its strategic layout in the Ningde Times commercial energy storage ecosystem, aiming for high-quality industry development[18] - The company’s digital entertainment segment is leveraging its acquisition of Holovis to enhance its immersive experience technology and expand international IP cooperation[19] Research and Development - Research and development expenses for the first three quarters of 2025 were CNY 15,282,951.81, slightly higher than CNY 14,223,737.55 in the same period of 2024[35] Other Financial Metrics - The company's cash and cash equivalents increased to ¥552,470,799.70 as of September 30, 2025, up from ¥422,144,708.03 at the end of 2024, representing a growth of 30.8%[21] - Accounts receivable rose to ¥643,257,185.33 as of September 30, 2025, compared to ¥569,718,737.07 at the end of 2024, indicating an increase of 12.9%[21] - Inventory increased significantly to ¥133,477,980.08 from ¥46,475,095.27, marking a growth of 187.5%[21] - Non-current assets totaled ¥912,018,828.54 as of September 30, 2025, up from ¥707,999,150.32 at the end of 2024, reflecting an increase of 28.8%[22] - The company's long-term equity investments increased to CNY 666,515,685.52 as of September 30, 2025, from CNY 461,498,262.60 at the end of 2024, representing a growth of approximately 44.5%[31] - The company's total owner's equity reached CNY 1,327,486,650.89 as of September 30, 2025, compared to CNY 1,291,734,292.40 at the end of 2024, reflecting an increase of about 2.8%[33] Accounting Standards - The company will not apply new accounting standards starting from 2025[39]